Extraordinary Dividend Announcement from Avance Gas On February 28, 2025, Avance Gas, a leading international provider of natural gas solutions, made an extraordinary announcement regarding a dividend payment. The dividend amount is set at $0.75 per share, payable in USD. Key Dates The following dates are important for shareholders regarding this dividend: Last day including…
A Tech-Savvy Showdown: Tesla, Coinbase, MicroStrategy, and Robinhood – A Modern Market Saga Welcome, dear reader, to an intriguing tale of modern market mavericks. In this captivating narrative, we’ll delve into the world of Tesla, Coinbase, MicroStrategy, and Robinhood. Buckle up as we explore how these technological titans are reshaping industries and redefining the investment…
Metallus: Unraveling the Impact of Q4 2024 Results on You and the World Canton, Ohio, February 28, 2025 – Metallus Inc. (MTUS), a leading player in high-quality specialty metals, manufactured components, and supply chain solutions, recently shared its financial performance for the fourth quarter and full year 2024. The company’s press release, issued on the…
Sinclair, Inc.: A Hidden Gem in the Broadcasting Industry Sinclair Broadcast Group, Inc. (Sinclair), a leading broadcasting company in the United States, has been flying under the radar for some time now. Despite its strategic investments and competitive advantages, the company’s stock price has remained relatively stagnant. In this blog post, we will delve deeper…
Bradda Head Lithium’s San Domingo Project: A Look Ahead Bradda Head Lithium Ltd, a mineral exploration and development company with listings on the AIM, OTC, and TSX-V stock exchanges (symbols: BHL, BHLIF, and BHLI respectively), has recently announced that it is targeting a production start at its San Domingo lithium project in late 2026. This…
Insights from Barbara Doran and Kevin Gordon on Market Action During the latest episode of ‘Closing Bell Overtime’, Barbara Doran, the CEO of BD8 Capital Partners, and Kevin Gordon, the senior investment strategist at Charles Schwab, shared their perspectives on the day’s market action. Both seasoned financial professionals provided valuable insights that could help investors…
Invesco Preferred ETF: A Closer Look at the Risks The Invesco Preferred Stock ETF (PGX) has been a popular choice among income-seeking investors due to its high yield. However, its duration of 9.47 years and heavy concentration in the financial sector make it a less desirable option for those who are risk-averse, especially in today’s…
Novartis’ Fabhalta®: A New Treatment Option for C3 Glomerulopathy Basel, Switzerland – February 28, 2025 – In a groundbreaking development for nephrology, Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting a marketing authorization for Fabhalta® (iptacopan). This first-in-class oral Factor B inhibitor…
